High blood pressure pill cuts risk of Parkinson's disease

Key points
- People taking a widely used group of drugs known as calcium channel blockers to treat high blood pressure also appear to be cutting their risk of Parkinson’s disease, according to a study published in the February 6, 2008, online issue of Neurology®, the medical journal of the American Academy of Neurology.
- The study involved 7,374 men and women over age 40.
- The study found people who were currently long-term users of calcium channel blockers to treat high blood pressure lowered their risk of Parkinson’s disease by 23 percent compared to people who didn’t take the drugs.
- “Long-term use of calcium channel blockers was associated with a reduced risk of developing Parkinson’s disease while no such association was seen for other high blood pressure medicines,” said study author Christoph R.
People taking a widely used group of drugs known as calcium channel blockers to treat high blood pressure also appear to be cutting their risk of Parkinson’s disease, according to a study published in the February 6, 2008, online issue of Neurology®, the medical journal of the American Academy of Neurology.
The study involved 7,374 men and women over age 40. Half of the group had Parkinson’s disease; the other half did not have Parkinson’s disease. Among both groups, nearly half used high blood pressure medications, such as calcium channel blockers, ACE inhibitors, AT II antagonists and beta blockers.
The study found people who were currently long-term users of calcium channel blockers to treat high blood pressure lowered their risk of Parkinson’s disease by 23 percent compared to people who didn’t take the drugs. There was no such effect among people taking ACE inhibitors, AT II antagonists and beta blockers.
“Long-term use of calcium channel blockers was associated with a reduced risk of developing Parkinson’s disease while no such association was seen for other high blood pressure medicines,” said study author Christoph R. Meier, PhD, MSc, with University Hospital Basel in Switzerland.
Meier says more research is needed to determine why calcium channel blockers appear to protect against Parkinson’s disease, whether this is indeed a causal association, and why the other high blood pressure medications do not offer a reduced risk.
###
The American Academy of Neurology, an association of more than 20,000 neurologists and neuroscience professionals, is dedicated to improving patient care through education and research. A neurologist is a doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as stroke, Alzheimer’s disease, epilepsy, Parkinson’s disease, and multiple sclerosis.
For more information about the American Academy of Neurology, visit www. aan.com.
Contact: Angela Babb
[email protected]
651-695-2789
American Academy of Neurology
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Heart & Blood Vessels →
NewsPaper highlights blood pressure risk in overweight children
Sophia Antipolis, 15 October 2010: The European Society of Cardiology (ESC) welcomes the findings of a paper presented today at the American Heart Association's High Blood Pressure Research 2010 Scientific Sessions…
18 October 2010
NewsBlacks Hospitalized for High Blood Pressure Five Times More Often than Whites
The hospital admission rate for Blacks with hypertension was 161 per 100,000 people in 2006 – nearly 5 times the hospitalization rate for Whites (33 admissions per 100,000), according to the latest News and Numbers from…
7 July 2010
NewsHigh fructose diet may contribute to high blood pressure
People who eat a diet high in fructose, in the form of added sugar, are at increased risk of developing high blood pressure, or hypertension, according to a study appearing in an upcoming issue of the Journal of the…





